Unlocking the Future of the Gastric Cancer Diagnostic Procedure Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the gastric cancer diagnostic procedure market right now?
There has been a substantial growth in the market size of gastric cancer diagnostic procedure in recent years. The market, valued at $1.44 billion in 2024, is predicted to increase to $1.54 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this historical period growth include innovative biopsy techniques, augmented research funding, the development of biomarker discovery, enhanced pathological examination, and alterations in screening regulations.
How fast Is the gastric cancer diagnostic procedure market expected to grow, and what’s its future value?
In the coming years, the market for gastric cancer diagnostic procedures is expected to witness significant expansion. The market size is projected to reach $2.07 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%. The anticipated growth during the forecast period can be ascribed to several factors such as the increase in point-of-care testing, the emergence of new biomarkers, the transition towards individualized medicine, the adoption of next-generation sequencing, and advancements in endoscopic imaging modalities. The forecast period is also expected to see key trends like the incorporation of nanotechnology, the usage of big data analytics, the application of microbiota analysis, the focus on patient-centered methods, and the role of telehealth in diagnostics.
Get your gastric cancer diagnostic procedure market report here!
What are the leading drivers of growth in the gastric cancer diagnostic procedure market?
The rise in gastrointestinal diseases is contributing significantly to the expansion of the gastric cancer diagnostic procedure market. These are diseases that impact multiple sections of the digestive system as well as supporting organs such as the liver and pancreas. Diagnostic procedures for gastric cancer, which include endoscopic and biopsy treatments, are typically used to treat stomach cancer. The growth of the gastric cancer diagnostic procedure market, therefore, is directly linked to the escalation of gastrointestinal diseases. For example, a report published by the GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, in August 2022, revealed that out of 73,076 individuals from 33 countries in a study, 40% of the participants were affected by a functional gastrointestinal disorder. As a result, the rise in gastrointestinal diseases is fostering the growth of the gastric cancer diagnostic procedure market.
What are the key segments defining the gastric cancer diagnostic procedure market?
The gastric cancer diagnostic procedure market covered in this report is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents And Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology, Immunohistochemistry
4) By Lab Tests: Blood Tests, Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests, Liquid Biopsies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp
Who are the key players steering the development of the gastric cancer diagnostic procedure market?
Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.
What emerging trends are influencing the growth of the gastric cancer diagnostic procedure market?
Rapid technological advancements are becoming increasingly popular in the gastric cancer diagnostic market. Major industry players are introducing innovative technologies to maintain their market presence. Take for instance, Ibex Medical Analytics, an Israel-based firm that utilises AI for diagnostics catered to healthcare institutions, they unveiled Galen Gastric in June 2022. Touted as the first AI-based solution for detecting gastric cancer worldwide, Galen Gastric is a comprehensive diagnostic instrument that aids pathologists in detecting stomach cancer, H. pylori, along with other important clinical results. It also expedites the turnaround times and enhances diagnostic processes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12038
Which regions are most influential in expanding the gastric cancer diagnostic procedure market?
North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Mobility Aids And Transportation Equipment Global Market Report 2024
Passenger Air Transport Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/passenger-air-transport-global-market-report
Chartered Air Transport Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chartered-air-transport-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
